Latest Articles

Article Type

Open Access
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
Sarah E. Corcoran, Reena Halai and Matthew A. Cooper
Clive Page, ASSOCIATE EDITOR

Pharmacological Reviews July 2021, 73 (3) 968-1000; DOI: https://doi.org/10.1124/pharmrev.120.000171
You have access
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
Qiang Ma, ASSOCIATE EDITOR

Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096
Open Access
Unlocking G-Quadruplexes as Antiviral Targets
Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
Rhian Touyz, ASSOCIATE EDITOR

Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230
Open Access
The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
Samantha Christine Sernoskie, Alison Jee and Jack Paul Uetrecht
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2021, 73 (3) 861-896; DOI: https://doi.org/10.1124/pharmrev.120.000090
You have access
Correction to “Sex- and Gender-Based Pharmacological Response to Drugs”
Pharmacological Reviews April 2021, 73 (2) 860; DOI: https://doi.org/10.1124/pharmrev.120.000206err
You have access
Modeling Pharmacokinetic Natural Product–Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach
Emily J. Cox, Dan-Dan Tian, John D. Clarke, Allan E. Rettie, Jashvant D. Unadkat, Kenneth E. Thummel, Jeannine S. McCune and Mary F. Paine
Hyunyoung Jeong, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 847-859; DOI: https://doi.org/10.1124/pharmrev.120.000106
Open Access
Viral G Protein–Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases
Timo W. M. De Groof, Elizabeth G. Elder, Marco Siderius, Raimond Heukers, John H. Sinclair and Martine J. Smit
Gunnar Schulte, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 828-846; DOI: https://doi.org/10.1124/pharmrev.120.000186
Open Access
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner and Tom E. Mollnes
Finn Olav Levy, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 792-827; DOI: https://doi.org/10.1124/pharmrev.120.000072
You have access
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
Jaclyn N. Highland, Panos Zanos, Lace M. Riggs, Polymnia Georgiou, Sarah M. Clark, Patrick J. Morris, Ruin Moaddel, Craig J. Thomas, Carlos A. Zarate, Edna F. R. Pereira and Todd D. Gould
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 763-791; DOI: https://doi.org/10.1124/pharmrev.120.000149
You have access
Sex- and Gender-Based Pharmacological Response to Drugs
Franck Mauvais-Jarvis, Heiner K. Berthold, Ilaria Campesi, Juan-Jesus Carrero, Santosh Dhakal, Flavia Franconi, Ioanna Gouni-Berthold, Mark L. Heiman, Alexandra Kautzky-Willer, Sabra L. Klein, Anne Murphy, Vera Regitz-Zagrosek, Karen Reue and Joshua B. Rubin
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 730-762; DOI: https://doi.org/10.1124/pharmrev.120.000206

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals